KBS Corporate Advises on the Sale of E-Dataware Ltd
ClearCourse Partnership, backed by New York-based Private Equity fund Aquiline Capital, has acquired E-Dataware Limited for an undisclosed fee.
Based in West Yorkshire, E-Dataware Limited, trading as e-clinic, provides patient and clinic management software for the healthcare sector.
The business was founded in 2002, and specialises in software which simplifies operations via workflow management and workload automation within the medical clinic sector. This has led to e-clinic gaining multiple blue chip and global clients. The business proved particularly attractive to acquirers due to the focus on innovation, which has made e-clinic a forerunner within either field; seen by the introduction of automated text messages, multi-layered diaries and integrated card payments.
The shareholders instructed KBS Corporate with the sale of the company in order to expediate their retirement plans. A diverse marketing strategy was instigated which resulted in several offers being presented.
ClearCourse Partnership LLP was the eventual buyer backed by Aquiline Capital Partners, who are currently on an aggressive buy-and-build strategy. As a result, e-clinic marks ClearCourse’s 13th acquisition since October 2018. ClearCourse motivation for the acquisition is to further their product offerings and to diversify.
Gerry Gualtieri, CEO of ClearCourse, commented,
“e-clinic is a dynamic new addition to ClearCourse Partnership. The company has developed a strong reputation in the healthcare sector for delivering first-class management solutions to an impressive list of clients around the world. We see great opportunity for commercial synergies between e-clinic and the wider Partnership, particularly around the provision of payments and membership management tools. We’re excited to work closely with the team to realise those synergies and support the Company’s continued growth and development.”
Mark Lainchbury, Managing Director of e-clinic added,
“We’re very proud to have build e-clinic into the highly successful, market-leading business that it is today. By joining the ClearCourse Partneship, we have access to a valuable range of resources and operational expertise that will allow us to continues to grow, develop and realise our ambitious plans for the future. We remain dedicated to creating the best possible product for our clients so that we can continue to improve patient care around the world.”
Advice was given for the seller by Guy Haynes and Matthew Sibley from KBS Corporate, and from Gateley PLC (Khurshid Valli and Poppy Ball) on the legal side. Legal advice for the buyers was provided by Squire Patton Boggs.